FREE DESIGN AUDIT
Free Design Audit Available - Click Here for Details

Blog

- ANNOUNCEMENTS

Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint Fusion and Pelvic Fixation of Pedicle Screw Constructs

March 31, 2026

AUSTIN, Texas, March 31, 2026 /PRNewswire/ — Genesys Spine today announced the successful completion of the first surgical procedure utilizing the SIros-X System, a next-generation solution designed to deliver precision, adaptability, and control for complex sacroiliac joint fusion and pelvic fixation. The inaugural case was performed by Scott L. Parker, M.D., at Ascension Saint Thomas Hospital Midtown, Nashville, TN, marking an important milestone as the system begins clinical use.

Read More »

Olympus Launches Next-Generation Surgical Imaging Platform in U.S.

March 11, 2026

WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ — Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization, workflow efficiency, and multispecialty flexibility. The VISERA ELITE III platform is a significant leap forward in surgical imaging and the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture established in 2013.

Read More »

XYRA Announces Issuance of US Patent to Reduce the Risk of Heart Failure or Strokes by Reducing the Number and Duration of Atrial Fibrillations

March 4, 2026

LOS ALTOS, Calif., March 4, 2026 /PRNewswire/ — XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose adjusted budiodarone for the treatment of atrial fibrillation (AF), with monitoring to correspondingly reduce or delay the risk of stroke and/or congestive heart failure.

Read More »

Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors

March 4, 2026

MINNETONKA, Minn., March 4, 2026 /PRNewswire/ — Monteris Medical, the leader in minimally invasive neurosurgical technology with its NeuroBlate® System, announced today that a newly published randomized prospective study in the distinguished journal Nature Communications suggests that laser interstitial thermal therapy (LITT) using NeuroBlate may enhance the effectiveness of the immunotherapy drug pembrolizumab (Keytruda®) for patients with recurrent high grade astrocytoma, including glioblastoma (GBM).

Read More »